STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
In brief
This study will evaluate the efficacy and safety of ADX-324 in participants with Type 1 or Type 2 hereditary angioedema. The study will also evaluate safety, pharmacokinetics (PK), pharmacodynamics (PD), and health-related quality of life measures.
Key facts
- Study ID
- NCT06960213
- Run by
- ADARx Pharmaceuticals, Inc.
- People needed
- 90
- Starts
- 2025-08-28
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-06-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- ADARx Clinical Site — Zagreb, Croatia (enrolling)
- ADARx Clinical Site — Hradec Králové, Czechia (enrolling)
- ADARx Clinical Site — Little Rock, Arkansas, United States (enrolling)
- ADARx Clinical Site — Split, Croatia (enrolling)
- ADARx Clinical Site — San Diego, California, United States (enrolling)
- ADARx Clinical Site — Wheaton, Maryland, United States (enrolling)
- ADARx Clinical Site — Walnut Creek, California, United States (enrolling)
- ADARx Clinical Site — St Louis, Missouri, United States (enrolling)
- ADARx Clinical Site — Orlando, Florida, United States (enrolling)
- ADARx Clinical Site — Litchfield Park, Arizona, United States (enrolling)
- ADARx Clinical Site — Chevy Chase, Maryland, United States (enrolling)
- ADARx Clinical Site — Columbus, Ohio, United States (enrolling)
- ADARx Clinical Site — Toledo, Ohio, United States (enrolling)
- ADARx Clinical Site — Hershey, Pennsylvania, United States (enrolling)
- ADARx Clinical Site — Detroit, Michigan, United States (enrolling)
- ADARx Clinical Site — Buenos Aires, Buenos Aires F.D., Argentina (enrolling)
- ADARx Clinical Site — Adelaide, South Australia, Australia (enrolling)
- ADARx Clinical Site — Vienna, Austria (enrolling)
- ADARx Clinical Site — Las Vegas, Nevada, United States (enrolling)
- ADARx Clinical Site — Sofia, Bulgaria (enrolling)
- ADARx Clinical Site — New York, New York, United States (enrolling)
- ADARx Clinical Site — Ottawa, Ontario, Canada (enrolling)
- ADARx Clinical Site — Cincinnati, Ohio, United States (enrolling)
- ADARx Clinical Site — Beijing, China (enrolling)
- ADARx Clinical Site — Prague, Czechia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.